GeneDx Holdings Corp. (WGS)
136.37
+0.43
(+0.32%)
USD |
NASDAQ |
Dec 18, 16:00
136.00
-0.37
(-0.27%)
After-Hours: 18:16
GeneDx Holdings Research and Development Expense (Annual): 44.80M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Illumina, Inc. | 1.167B |
| Labcorp Holdings, Inc. | -- |
| Delcath Systems, Inc. | 13.87M |
| Star Operating Cos., Inc. | -- |
| CytoSorbents Corp. | 6.916M |